During the past decade, Rundum Onkologie am Bahnhofpark conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rundum Onkologie am Bahnhofpark" are "Adenocarcinoma" (1 trials), "Bone Metastases" (1 trials), "Breast Cancer" (1 trials), "Early Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Rundum Onkologie am Bahnhofpark" in a lesser frequency.

Most popular intervention types in "Rundum Onkologie am Bahnhofpark" are "Drug" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Activity program" (1 trials), "Control" (1 trials), "Denosumab (reduced dosing)" (1 trials), "Denosumab (standard dosing)" (1 trials) and "Eribulin mesilate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rundum Onkologie am Bahnhofpark" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Rundum Onkologie am Bahnhofpark". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rundum Onkologie am Bahnhofpark, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rundum Onkologie am Bahnhofpark, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".